Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent ; volume:8 ; number:1 ; day:12 ; month:6 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (12.6.2018), 1-13, 12.2018
- Creator
-
Ayoub, Bassam M.
- Contributor
-
Mowaka, Shereen
Safar, Marwa M.
Ashoush, Nermeen
Arafa, Mona G.
Michel, Haidy E.
Tadros, Mariam M.
Elmazar, Mohamed M.
Mousa, Shaker A.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-27395-0
- URN
-
urn:nbn:de:101:1-2018081322104379854228
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:40 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ayoub, Bassam M.
- Mowaka, Shereen
- Safar, Marwa M.
- Ashoush, Nermeen
- Arafa, Mona G.
- Michel, Haidy E.
- Tadros, Mariam M.
- Elmazar, Mohamed M.
- Mousa, Shaker A.
- SpringerLink (Online service)
Other Objects (12)
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Drug repositioning
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
Redefinition of Atypical Parkinsonian Syndromes
TSPO imaging in parkinsonian disorders
Neural Correlates of Parkinsonian Syndromes
Transcriptome-Guided Drug Repositioning
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Modeling the origin of parkinsonian tremor
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Drug repositioning
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
Redefinition of Atypical Parkinsonian Syndromes
TSPO imaging in parkinsonian disorders
Neural Correlates of Parkinsonian Syndromes
Transcriptome-Guided Drug Repositioning
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Modeling the origin of parkinsonian tremor
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Drug repositioning
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
Redefinition of Atypical Parkinsonian Syndromes
TSPO imaging in parkinsonian disorders
Neural Correlates of Parkinsonian Syndromes
Transcriptome-Guided Drug Repositioning
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis